Revance Therapeutics Inc (NASDAQ:RVNC) Shareholder Alert: Lawsuit Alleges Misleading Statements
An investor, who purchased shares of Revance Therapeutics Inc (NASDAQ:RVNC), filed a lawsuit over alleged violations of Federal Securities Laws by Revance Therapeutics regarding certain allegedly false and misleading statements made in connection with Revance Therapeutics' June 19, 2014 follow-on public stock offering.
View full press release